Quality assessment of ciprofloxacin tablets obtained from community pharmacies in Lagos, Nigeria

Simple item page
dc.contributor.authorJoda, A.E.
dc.contributor.authorTayo, F
dc.contributor.authorAina, B.A.
dc.date.accessioned2019-12-09T10:02:24Z
dc.date.available2019-12-09T10:02:24Z
dc.date.issued2018
dc.descriptionStaff publicationsen_US
dc.description.abstractCiprofloxacin is increasingly being used in the management of various cases of infectious diseases including gonorrhoea and acute exacerbation of chronic bronchitis. As bioavailability and bioequivalence of drug products (especially multi-sourced products) and product selection have emerged as critical issues in healthcare, it is essential that products used in patient management are of acceptable quality. Using a sampling frame of community pharmacists in Lagos obtained from the Association of Community Pharmacists of Nigeria (ACPN) Lagos State Branch, sixteen brands of ciprofloxacin (500 mg) tablets were purchased from selected pharmacies for the study. Physicochemical tests were carried out according to BP (2007) specifications. The results showed that the products had acceptable physical quality thus satisfactory in appearance, size and ability to abrade or be crushed. All but one of the brands tested passed the dissolution tests. A quarter of the brands tested (25%) did not pass the chemical assay test i.e. percentage content of active ingredient. The study concluded that not all the products tested are of sufficiently good quality with up to four brands failing the chemical assay test. This may be due to deliberate counterfeiting, failure of current good manufacturing practices (cGMP) by manufacturers or poor handling by wholesalers/retailers. This has serious impact on healthcare delivery and public health. The study recommends effective post marketing surveillance and enforcement of cGMP. Future analytical studies on ciprofloxacin should consider dissolution testing in solutions of different pH.en_US
dc.description.sponsorshipThe study was funded by the authorsen_US
dc.identifier.citationJoda, A.E., Tayo, F and Aina, B.A. (2018). Quality assessment of ciprofloxacin tablets obtained from community pharmacies in Lagos, Nigeria. Ife Journal of Science, 20(1):155-168.en_US
dc.identifier.issn0794-4896
dc.identifier.urihttps://ir.unilag.edu.ng/handle/123456789/7048
dc.language.isoenen_US
dc.publisherIfe Journal of Scienceen_US
dc.relation.ispartofseriesIfe Journal of Science;Vol.20(1)
dc.subjectCiprofloxacinen_US
dc.subjectQualityen_US
dc.subjectGMPen_US
dc.subjectDrug fakingen_US
dc.subjectPharmacyen_US
dc.subjectCommunity pharmacyen_US
dc.subjectInfectious diseasesen_US
dc.subjectResearch Subject Categories::PHARMACYen_US
dc.titleQuality assessment of ciprofloxacin tablets obtained from community pharmacies in Lagos, Nigeriaen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
2018 20(1) - IJS - QUALITY ASSESSMENT OF CIPROFLOXACIN TABLETS.pdf
Size:
697.83 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Clinical Pharmacy and Biopharmacy- Scholarly Publications